Brief: IX Biopharma Proposes Placement Of 13.7 Million New Ordinary Shares
12/07/2022 12:25
July 12 (Reuters) - IX Biopharma Ltd IXBI.SI :
* PROPOSED PLACEMENT OF 13,710,000 NEW ORDINARY SHARES
* PLACEMENT AT S$0.20 PER SUBSCRIPTION SHARE
Source text for Eikon: ID:nSN7tBsGj
Further company coverage: IXBI.SI
Recent news on IX Biopharma
See all newsBrief: Ix Biopharma Confirms Orion Not Yet Obtained Licence From Nevada State Board Of Pharmacy
Brief: Ix Biopharma Says U.S. Govt Opens Emergency Pathway, Clears Path For Wafermine Application For EUA
Brief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine